Antitrust activities in the pharmaceutical industry

04:28 EDT 1 Jun 2018 | Generics and Biosimilars Initiative

High prices of prescription drugs have been highlighted as reducing access to essential drugs and have recently gained notoriety and political attention. Authors from Harvard Medical School and the law schools of the Northeastern and Rutgers Universities explain the role of antitrust law in restoring competition and restraining price increases [1].

Original Article: Antitrust activities in the pharmaceutical industry

More From BioPortfolio on "Antitrust activities in the pharmaceutical industry"